Cargando…

Translating translational medicine into global health equity: What is needed?

While genomics, and other omics, research is rapidly advancing in the US and Europe, progress has been slower in less resourced countries. The imbalance has given rise to concern about whether the benefits of these advances, namely new and better tests, treatments, risk identification, and preventio...

Descripción completa

Detalles Bibliográficos
Autor principal: Isaacson Barash, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911426/
https://www.ncbi.nlm.nih.gov/pubmed/27354940
http://dx.doi.org/10.1016/j.atg.2016.03.004
_version_ 1782438127344812032
author Isaacson Barash, Carol
author_facet Isaacson Barash, Carol
author_sort Isaacson Barash, Carol
collection PubMed
description While genomics, and other omics, research is rapidly advancing in the US and Europe, progress has been slower in less resourced countries. The imbalance has given rise to concern about whether the benefits of these advances, namely new and better tests, treatments, risk identification, and prevention strategies, will be shared and available to those living in less resourced reaches of the globe. In effort to give voice to researchers, an informal survey about barriers to advancing translational medicine was administered to attendees of the 11th Asia Pacific Conference on Human Genetics, 2015, Hanoi. The overall goal of the survey was to identify unmet needs and rank their importance. Most attendees completed the survey. Not surprisingly funding is indicated as a major need. Respondents reported that lack of bioinformatics and computational tools, trained data scientists and access to datasets is creating a significant lag behind better resourced regions. Results are intended to inform efforts to create a regional consensus statement of need. Such a regional statement could help funding organizations and policy makers seeking to promote global genomics benefit sharing.
format Online
Article
Text
id pubmed-4911426
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-49114262016-06-28 Translating translational medicine into global health equity: What is needed? Isaacson Barash, Carol Appl Transl Genom Article While genomics, and other omics, research is rapidly advancing in the US and Europe, progress has been slower in less resourced countries. The imbalance has given rise to concern about whether the benefits of these advances, namely new and better tests, treatments, risk identification, and prevention strategies, will be shared and available to those living in less resourced reaches of the globe. In effort to give voice to researchers, an informal survey about barriers to advancing translational medicine was administered to attendees of the 11th Asia Pacific Conference on Human Genetics, 2015, Hanoi. The overall goal of the survey was to identify unmet needs and rank their importance. Most attendees completed the survey. Not surprisingly funding is indicated as a major need. Respondents reported that lack of bioinformatics and computational tools, trained data scientists and access to datasets is creating a significant lag behind better resourced regions. Results are intended to inform efforts to create a regional consensus statement of need. Such a regional statement could help funding organizations and policy makers seeking to promote global genomics benefit sharing. Elsevier 2016-03-10 /pmc/articles/PMC4911426/ /pubmed/27354940 http://dx.doi.org/10.1016/j.atg.2016.03.004 Text en © 2016 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Isaacson Barash, Carol
Translating translational medicine into global health equity: What is needed?
title Translating translational medicine into global health equity: What is needed?
title_full Translating translational medicine into global health equity: What is needed?
title_fullStr Translating translational medicine into global health equity: What is needed?
title_full_unstemmed Translating translational medicine into global health equity: What is needed?
title_short Translating translational medicine into global health equity: What is needed?
title_sort translating translational medicine into global health equity: what is needed?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911426/
https://www.ncbi.nlm.nih.gov/pubmed/27354940
http://dx.doi.org/10.1016/j.atg.2016.03.004
work_keys_str_mv AT isaacsonbarashcarol translatingtranslationalmedicineintoglobalhealthequitywhatisneeded